Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

iRGD-peptide-conjugated doxorubicin/sorafenib-loaded lipid-polymer hybrid nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

1

poly(lactic-co-glycolic acid)

PLGA
Type Polymer
Formula
Role core
2

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000

MAL-PEG-DSPE
Type Polymer
Formula
Role layer
3

lecithin

Type Complex Compound
Formula
Role layer
4

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide

sorafenib SFN SOR SF
Type Single Compound
Formula C21H16ClF3N4O3
Role loaded material
5

adriblastin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material
6

iRGD peptide

iRGD
Type Biomolecule
Formula
Role layer

Properties

General physical and chemical properties

Property Value Source
colloidal stability dependent on precursor ratio

0 more entry available to subscribers only.

Or, view sample content

Applications

Area Application Source
medicine/veterinary

0 more entry available to subscribers only.

Or, view sample content

Characterization

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Product

iRGD-peptide-conjugated doxorubicin/sorafenib-loaded lipid-polymer hybrid nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial